NIB Holdings Ltd (ASX: NHF) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
NIB Holdings Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
NIB Holdings Ltd (ASX: NHF)
Latest News
Opinions
Insurance profits increased 400% in FY23. Here are the ASX shares I'd buy
Dividend Investing
These ASX 200 dividend stocks have been named as buys in September
Dividend Investing
Show us the money! The ASX shares delivering the best dividend upgrades this earnings season
Share Gainers
Here are the top 10 ASX 200 shares today
Share Gainers
Why Audinate, Breville, NIB, and Premier Investments shares are roaring higher
Earnings Results
NIB share price charges higher amid 43% profit boost for the ASX 200 health insurer
Earnings Results
Experts forecast the ASX 200 winners and losers this earnings season
Healthcare Shares
3 reasons why I think NIB shares could still be a buy
Broker Notes
3 ASX 200 shares just upgraded by top brokers
Healthcare Shares
4 things to look for when buying ASX healthcare shares
Share Market News
Here are the top 10 ASX 200 shares today
Financial Shares
Why this top broker says buy NIB shares over Medibank
Frequently Asked Questions
-
The company was established as Newcastle Industrial Benefits (NIB) Hospital Fund in 1952 to provide health insurance for workers at BHP Steelworks, Mayfield. It changed its name to NIB Health Funds Ltd in 1966.
In 2007 members voted in favour of demutualising the health fund, and in November that year, NIB became the first Australian private health insurer to list on the ASX.
-
NIB has paid out twice-yearly dividends – in April and October — every year since 2009. Its latest payout was a final dividend of 11 cents a share in October 2022.
Dividend Payment History Data provided by Morningstar.
Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
07 Mar 2024 | $0.1500 | 100.00% | Interim | 10 Apr 2024 |
04 Sep 2023 | $0.1500 | 100.00% | Final | 03 Oct 2023 |
02 Mar 2023 | $0.1300 | 100.00% | Interim | 03 Apr 2023 |
05 Sep 2022 | $0.1100 | 100.00% | Final | 04 Oct 2022 |
03 Mar 2022 | $0.1100 | 100.00% | Interim | 04 Apr 2022 |
02 Sep 2021 | $0.1400 | 100.00% | Final | 05 Oct 2021 |
04 Mar 2021 | $0.1000 | 100.00% | Interim | 06 Apr 2021 |
03 Sep 2020 | $0.0400 | 100.00% | Final | 06 Oct 2020 |
05 Mar 2020 | $0.1000 | 100.00% | Interim | 07 Apr 2020 |
02 Sep 2019 | $0.1300 | 100.00% | Final | 30 Sep 2019 |
06 Sep 2018 | $0.1100 | 100.00% | Final | 05 Oct 2018 |
01 Mar 2018 | $0.0900 | 100.00% | Interim | 03 Apr 2018 |
07 Sep 2017 | $0.0000 | 100.00% | Final | 06 Oct 2017 |
02 Mar 2017 | $0.0850 | 100.00% | Interim | 03 Apr 2017 |
08 Sep 2016 | $0.0900 | 100.00% | Final | 07 Oct 2016 |
02 Mar 2016 | $0.0575 | 100.00% | Interim | 01 Apr 2016 |
10 Sep 2014 | $0.0900 | 100.00% | Special Cash | 03 Oct 2014 |
10 Sep 2014 | $0.0575 | 100.00% | Final | 03 Oct 2014 |
05 Sep 2013 | $0.0500 | 100.00% | Final | 04 Oct 2013 |
04 Mar 2013 | $0.0500 | 100.00% | Interim | 05 Apr 2013 |
05 Mar 2012 | $0.0425 | 100.00% | Interim | 05 Apr 2012 |
07 Mar 2011 | $0.0400 | 100.00% | Interim | 08 Apr 2011 |
05 Mar 2010 | $0.0200 | 100.00% | Interim | 08 Apr 2010 |
14 Sep 2009 | $0.0440 | 100.00% | Final | 09 Oct 2009 |
NHF ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About NIB Holdings Ltd
NIB Holdings Limited (ASX: NHF) provides health and medical insurance to more than 1.5 million Australian and New Zealand residents.
In addition, it covers more than 180,000 international students and workers in Australia.
The company also offers travel insurance through its NIB Travel business, and provides health insurance plans to corporate groups through its GU Health business.
The NIB share price hit an all-time high of $8.18 on 31 August 2022.
NHF Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
24 Apr 2024 | $7.56 | $-0.03 | -0.40% | 2,345,832 | $7.63 | $7.67 | $7.53 |
23 Apr 2024 | $7.59 | $0.04 | 0.53% | 422,792 | $7.58 | $7.61 | $7.51 |
22 Apr 2024 | $7.55 | $0.16 | 2.17% | 386,092 | $7.53 | $7.59 | $7.50 |
19 Apr 2024 | $7.39 | $-0.17 | -2.25% | 847,308 | $7.49 | $7.50 | $7.31 |
18 Apr 2024 | $7.56 | $-0.05 | -0.66% | 518,907 | $7.60 | $7.66 | $7.53 |
17 Apr 2024 | $7.61 | $0.09 | 1.20% | 631,869 | $7.52 | $7.66 | $7.52 |
16 Apr 2024 | $7.52 | $-0.23 | -2.97% | 656,483 | $7.73 | $7.75 | $7.47 |
15 Apr 2024 | $7.75 | $-0.01 | -0.13% | 475,661 | $7.78 | $7.79 | $7.70 |
12 Apr 2024 | $7.76 | $0.06 | 0.78% | 543,774 | $7.67 | $7.76 | $7.62 |
11 Apr 2024 | $7.70 | $-0.09 | -1.16% | 547,872 | $7.69 | $7.75 | $7.66 |
10 Apr 2024 | $7.79 | $-0.03 | -0.38% | 709,635 | $7.86 | $7.87 | $7.75 |
09 Apr 2024 | $7.82 | $0.01 | 0.13% | 780,959 | $7.78 | $7.85 | $7.78 |
08 Apr 2024 | $7.81 | $0.12 | 1.56% | 617,540 | $7.71 | $7.85 | $7.69 |
05 Apr 2024 | $7.69 | $-0.07 | -0.90% | 701,638 | $7.74 | $7.75 | $7.65 |
04 Apr 2024 | $7.76 | $0.04 | 0.52% | 595,724 | $7.79 | $7.83 | $7.72 |
03 Apr 2024 | $7.72 | $-0.26 | -3.26% | 784,170 | $7.88 | $7.92 | $7.68 |
02 Apr 2024 | $7.98 | $0.12 | 1.53% | 1,056,329 | $7.86 | $8.02 | $7.81 |
28 Mar 2024 | $7.86 | $0.08 | 1.03% | 1,250,004 | $7.79 | $7.86 | $7.70 |
27 Mar 2024 | $7.78 | $0.13 | 1.70% | 708,693 | $7.68 | $7.78 | $7.67 |
26 Mar 2024 | $7.65 | $0.00 | 0.00% | 706,881 | $7.68 | $7.69 | $7.56 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
18 Apr 2024 | Mark Fitzgibbon | Transfer | 20,000 | $152,000 |
Off-market transfer.
|
18 Apr 2024 | Mark Fitzgibbon | Transfer | 20,000 | $152,000 |
Off-market transfer.
|
12 Mar 2024 | Mark Fitzgibbon | Sell | 35,000 | $277,018 |
On-market trade.
|
08 Dec 2023 | Jill Watts | Buy | 3,154 | $23,497 |
On-market trade.
|
01 Dec 2023 | Mark Fitzgibbon | Issued | 195,046 | $1,503,804 |
Issue of securities. 9,19,837 Rights
|
23 Nov 2023 | Mark Fitzgibbon | Transfer | 22,000 | $165,000 |
Off-market transfer.
|
23 Nov 2023 | Mark Fitzgibbon | Transfer | 22,000 | $165,000 |
Off-market transfer.
|
22 Nov 2023 | Jill Watts | Buy | 162 | $1,200 |
On-market trade.
|
20 Nov 2023 | Jill Watts | Buy | 4,021 | $29,996 |
On-market trade.
|
01 Sep 2023 | Mark Fitzgibbon | Issued | 139,730 | $1,151,375 |
Conversion of securities.
|
01 Sep 2023 | Mark Fitzgibbon | Expiry | 60,902 | $501,832 |
As advised by the company. Lapsed, 7,24,791 Rights
|
01 Sep 2023 | Mark Fitzgibbon | Sell | 35,000 | $288,464 |
On-market trade.
|
01 Sep 2023 | Mark Fitzgibbon | Issued | 86,977 | $716,690 |
Issue of securities.
|
01 Sep 2023 | Mark Fitzgibbon | Exercise | 139,730 | $1,151,375 |
Conversion of securities. 7,85,693 Rights
|
31 Aug 2023 | Mark Fitzgibbon | Sell | 35,000 | $290,511 |
On-market trade.
|
28 Aug 2023 | Mark Fitzgibbon | Transfer | 30,000 | $243,000 |
Off-market transfer.
|
28 Aug 2023 | Mark Fitzgibbon | Transfer | 30,000 | $243,000 |
Off-market transfer.
|
21 Jun 2023 | Mark Fitzgibbon | Sell | 5,000 | $44,564 |
On-market trade.
|
16 Jun 2023 | Mark Fitzgibbon | Sell | 6,010 | $51,750 |
On-market trade.
|
15 Jun 2023 | Mark Fitzgibbon | Sell | 53,990 | $464,895 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr David L Gordon | Non-Executive DirectorNon-Executive Chairman | May 2020 |
Mr Gordon has over 30 years of experience as a director of both public and private companies and in corporate advisory roles to Australian and international organizations. He brings knowledge of mergers and acquisitions, as well as capital raisings, IPOs, and joint ventures. He also has a track record in guiding businesses to grow and harness their digital capability to explore and develop new products and markets. He has held several senior roles with Freehills (Partner) and boutique investment bank Wentworth Associates (acquired by Investec in 2001). In addition, he founded independent corporate advisory and investment firm, Lexicon Partners in 2001.
|
Ms Anne Joan Loveridge | Non-Executive Director | Feb 2017 |
Ms Loveridge has over 35 years of experience in the regulated financial services sector, including health insurance. She has knowledge of financial and regulatory reporting, risk management and compliance frameworks. She also has over seven years of experience as a Non-Executive Director for ASX-listed entities in the financial services sector. Through senior leadership roles, Anne also has supported the role of leadership, performance, and culture in driving change. Formally trained as a Chartered Accountant, Anne has a breadth of experience in financial reporting, auditing, risk, ethics, and regulatory affairs following her 31 years with PwC in the UK and Australia, where she was a Senior Audit Partner and Deputy Chair of the Australian Firm until 2015. She is member of the Risk and Reputation Committee.
|
Mr Donal Paul O'Dwyer | Non-Executive Director | Mar 2016 |
Mr O'Dwyer has knowledge of the health industry globally, after more than 35 years in senior executive and Non-Executive Director roles within the healthcare products and medical device sectors. Starting his career as a qualified civil engineer, he went on to gain experience in business, science, engineering, manufacturing, and management. During his tenure with Baxter Healthcare, he rose through the ranks from plant manager to President of the Cardiovascular Group Europe, gaining understanding of the inner workings of business strategy and fiscal management, from the floor of the factory through to the boardroom. He then worked for Cordis (the cardiovascular device franchise of Johnson and Johnson) initially as European President and later, when he located to the US, he served as Worldwide President.
|
Mark Fitzgibbon | Chief Executive OfficerManaging Director | May 2007 |
Mr Fitzgibbon has held executive positions at several Australian organizations, including local government councils and peak bodies. Leading nib for the past 20 years, he has changed the business from a regionally based (Newcastle, NSW) private health insurer into one of Australia's growing and innovative health funds. As Managing Director, Mark's strategic focus has been to grow and diversify nib's business and with those earnings by leveraging nib's capability, systems, and people. This has seen nib grow in recent years organically and inorganically, both in existing and new markets.
|
Mr Peter Harmer | Non-Executive Director | Jul 2021 |
Mr Harmer has over 40 years of experience in the Australian and international insurance and financial sectors, including over 30 years in a senior executive capacity. He understands the global insurance and reinsurance markets and has driven the improvement of business and customer experiences through digital innovation. During his career, Peter enhanced digital engagement through reexamining customer journeys to understand pain points and introduced the right tools and technology to help improve the overall customer experience. In addition, he has been focused on the development and design of agile working methodologies combined with Human Centred Design thinking to ensure best practice in employee productivity, performance, health, and wellbeing. He is the Chair of the Risk and Reputation Committee.
|
Ms Jacqueline Chow | Non-Executive Director | Apr 2018 |
Ms Chow has more than 20 years of experience working with global blue-chip consumer product multinationals in a range of executive and non-executive positions in general management, strategy, marketing as well as technology and innovation. Her early career concentrated on business analytics, brand equity and marketing. With a reputation for driving growth and performance in global businesses, she is passionate about unlocking value through the entire value chain by growing consumer demand through disruptive technologies, innovation, and digital platforms. Jacqueline actively contributes toward ensuring the long-term sustainability of the organizations she serves in the areas of climate scenario impacts, human rights, and supply chain resilience.
|
Mr Brad Welsh | Non-Executive Director | Jul 2023 |
Mr Welsh, who has spent more than a decade leading and advising global resource companies including Energy Resources of Australia and Rio Tinto, brings both public sector and commercial skills to his role on nibs Board. He is currently Chief Executive Officer and Managing Director at Energy Resources of Australia. Among his previous roles he was Chief Adviser to the CEO - Indigenous Affairs, at Rio Tinto; Acting General Manager, Weipa, at Rio Tinto, and worked in the Office of the NSW Premier, the Minister for Planning, and the Prime Minister of Australia.
|
Ms Jill Watts | Non-Executive Director | Jul 2023 |
Ms Watts is a Non-Executive Director on the Boards of St Vincents Healthcare, Icon Cancer Group and IHH Healthcare Berhad, which is listed in Malaysia and Singapore, and has operations in Turkey, India, China, and Europe. She is on the Board of Lendleases retirement living business, known as Keyton. Prior to returning to Australia in 2017, she was the Group CEO of the UKs private hospital group BMI Healthcare, and Group CEO of Ramsay Healthcare, UK.
|
Ms Roslyn Toms | Group Executive - Legal and Chief Risk OfficerCompany Secretary | Apr 2013 |
-
|
Mr Jordan French | Senior Corporate CounselJoint Company Secretary | Aug 2017 |
-
|
Edward Close | Chief Executive - Australian Residents Health Insurance |
-
|
|
James Barr | Chief Executive - International Visitors |
-
|
|
Martin Adlington | Chief Executive - nib Thrive |
-
|
|
Rob Hennin | Chief Executive Officer - nib New Zealand and Travel |
-
|
|
Nick Freeman | Group Chief Financial Officer |
-
|
|
Brendan Mills | Group Chief Information Officer |
-
|
|
Lauren Daniels | Group Chief People Officer |
-
|
|
Roslyn Toms | Group Executive - Legal and Chief Risk Officer |
-
|
|
Roslyn Toms | Group Executive - Legal and Chief Risk OfficerCompany Secretary |
-
|
|
Jordan French | Senior Corporate CounselJoint Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
HSBC Custody Nominees (Australia) Limited | 77,169,011 | 15.96% |
Citicorp Nominees Pty Limited | 47,951,542 | 9.93% |
J P Morgan Nominees Australia Pty Limited | 47,754,468 | 9.88% |
National Nominees Limited | 19,129,457 | 3.96% |
BNP Paribas Noms Pty Ltd | 13,107,907 | 2.72% |
HSBC Custody Nominees (Australia) Limited i | 4,724,867 | 0.98% |
Bnp Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd | 2,775,852 | 0.57% |
Citicorp Nominees Pty Limited i | 2,517,739 | 0.52% |
BNP Paribas Nominees Pty Ltd | 1,806,166 | 0.37% |
BNP Paribas Noms (Nz) Ltd | 1,311,537 | 0.27% |
HSBC Custody Nominees (Australia) Limited ii | 1,201,417 | 0.25% |
Mr Mark Anthony Fitzgibbon | 1,084,491 | 0.22% |
BNP Paribas Nominees Pty Ltd i | 1,015,082 | 0.20% |
Netwealth Investments Limited | 874,961 | 0.18% |
Fitzy (Nsw) Pty Ltd | 874,621 | 0.18% |
Cpu Share Plans Pty Ltd | 779,213 | 0.16% |
Cpu Share Plans Pty Ltd i | 641,555 | 0.13% |
Netwealth Investments Limited i | 608,834 | 0.13% |
Neweconomy Com Au Nominees Pty Limited | 553,327 | 0.11% |
Cpu Share Plans Pty Ltd ii | 542,190 | 0.11% |